
ITI Pharma and Healthcare Fund (G)
Equity · Sectoral
13.58%
Last 1 year
- Exit Load
- 0.50%
- Expense Ratio
- 2.59%
- Min. AmountMin. SIP Amount
- ₹500
- Min. Lump SumMin. Lump sum
- ₹5,000
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹11,89,446
- IRR
- 17.483%
- Absolute Gain
- +₹2,89,446 (+32.2%)
Returns & Rankings
Category: Equity Sectoral


63 ProductsEquity Sectoral Funds


63 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- 1Y Returns
- 13.6%
- 3Y Returns
- 17.5%
- 5Y Returns
- 13.1%
- Alpha
- -2.31
Holding Analysis
Equity/Debt/Cash Split
- Equity98.8%
- Debt1.2%
Market Cap Weightage
- Large Cap46.7%
- Mid Cap36.4%
- Small Cap15.7%
- Others1.2%
Sector allocation
- Healthcare96.7%
- Materials2.1%
- Debt1.2%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Sun Pharma.Inds. | Pharmaceuticals | 11.67% |
| Divi's Lab. | Pharmaceuticals | 9.98% |
| Apollo Hospitals | Healthcare | 5.62% |
| Dr Reddy's Labs | Pharmaceuticals | 5.23% |
| Torrent Pharma. | Pharmaceuticals | 4.58% |
| Laurus Labs | Pharmaceuticals | 4.54% |
| Cipla | Pharmaceuticals | 4.28% |
| Max Healthcare | Healthcare | 4.14% |
| Aurobindo Pharma | Pharmaceuticals | 4.03% |
| Mankind Pharma | Pharmaceuticals | 3.75% |
- 11.67%
Sun Pharma.Inds.
Pharmaceuticals
- 9.98%
Divi's Lab.
Pharmaceuticals
- 5.62%
Apollo Hospitals
Healthcare
- 5.23%
Dr Reddy's Labs
Pharmaceuticals
- 4.58%
Torrent Pharma.
Pharmaceuticals
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 16.23% | 29.6% | |
| — | Equity | 28.41% | 28.89% | |
| — | Equity | 23.71% | 23.26% | |
| — | Equity | 20.06% | 21.85% | |
| — | Equity | 24.28% | 21.75% |
Peer Comparison
ITI Pharma and Healthcare Fund (G)
- 1 Y Return
- 13.58%
- 3 Y Return
- 17.48%
- 5 Y Return
- 13.14%
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Fund Management

Animesh Singh
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- -2.31
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 0.95
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.75
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 16.48
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- 0.03
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 58.81
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
ITI Pharma and Healthcare Fund – Regular Plan - Growth was launched 5 years ago and has delivered annualised returns (CAGR) of 13.05% since inception. Here is how it compares with the category average:
Period Fund Category average 1 Year 13.58% 6.93% 3 Years 17.48% 14.57% 5 Years 13.14% 11.55% Since Inception 13.05% Returns as on 18 Nov 2026. 1-year returns are absolute; returns above 1 year are CAGR. Past performance may or may not be sustained in future.
The expense ratio of ITI Pharma and Healthcare Fund – Regular Plan - Growth is 2.59%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
ITI Pharma and Healthcare Fund is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in ITI Pharma and Healthcare Fund with ₹500 a month, or invest a lump sum of ₹5,000. Additional investments start at ₹1,000.
ITI Pharma and Healthcare Fund charges an exit load of 0.5% if redeemed within 3 months of investment. The exit load is deducted from the redemption amount.
No, ITI Pharma and Healthcare Fund has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
ITI Pharma and Healthcare Fund manages assets (AUM) of approximately ₹267 Cr.
As on 31 Oct 2026, ITI Pharma and Healthcare Fund holds 38 securities. These are its top 10 holdings:
Company % of portfolio Sun Pharma.Inds. 11.67% Divi's Lab. 9.98% Apollo Hospitals 5.62% Dr Reddy's Labs 5.23% Torrent Pharma. 4.58% Laurus Labs 4.54% Cipla 4.28% Max Healthcare 4.14% Aurobindo Pharma 4.03% Mankind Pharma 3.75% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 96.70% Materials 2.08% Debt 1.22% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the ITI Mutual Fund website, MF Central or KARVY. The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.












